From the news

Recent transaction and litigation

Publications

November / 2012

Motion to Certify a Major Class Action Dismissed

Meitar successfully defended an accounting firm in defending against a motion to certify a multimillion dollar class action claim, leading to the denial of the motion. The plaintiffs have filed an appeal to the Supreme Court, which is pending. The claim involves novel issues of securities law and professional negligence as applied to class action claims.

November / 2012

Advising Cisco in its Acquisition of Intucell

Meitar acted as local counsel for Cisco in its acquisition of Intucell an advanced self-optimizing network (SON) software privately held Israeli company.

November / 2012

Hypertoy Wins a Trademark Infringement Action

Meitar successfully represented Hypertoy in a legal action and a motion for a preliminary injunction relating to infringement of the trademark “TOY PLANET”, leading to the cessation of all infringing activities.

November / 2012

Representation of Nolio in its acquisition by CA Technologies

Meitar represented Israeli app deployment and management company Nolio in its acquisition by IT software giant CA Technologies.

November / 2012

Representation of Enzymotec in its initial public offering on NASDAQ

Meitar represented Enzymotec Ltd., a developer of lipid-based products and solutions for the nutritional and healthcare markets, in its initial public offering on NASDAQ raising approximately $70M (including exercise at closing of the underwriters’ overallotment option in full). Bank of America Merrill Lynch and Jefferies LLC acted as joint book-running managers for the offering.

November / 2011

Representation of Avaya in its acquisition of Radvision for approximately $230 million in cash

Meitar represented Avaya, a business communications solutions provider, in its acquisition of Radvision, a Tel Aviv-based company developing HD and converged video conferencing solutions, for approximately $230 million in cash. The transaction is expected to be completed during the second quarter of 2012.

November / 2011

Covidien in its acquisition of SuperDimension

Meitar represented Covidien, a U.S. medical device manufacturer, in its acquisition of SuperDimension, an Israeli company with a cutting-edge technology for minimally-invasive surgical procedures on the lungs, for $300 million in cash, with future earn out payments possible. The transaction is expected to be completed during the second quarter of 2012.